Clinical and oncological impact of muscle-related parameters in oesophagogastric cancer

Read full text Summarise with VIRAT
Authors: Yannick Deswysen, Étienne Danse, Alix Collard, Marc Van den Eynde, Nicolas Lanthier, Belgian Week of Gastroententerology
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Introduction Oesophagogastric cancer remains a disease associated with poor survival rates. Assessing muscle mass and quality can help identify patients with reduced muscle mass (myopenia) and muscle fat infiltration (myosteatosis). Aim To assess body composition (muscle mass and muscle quality) in patients with oesophageal or gastric cancer, and to analyse clinical associations and oncological outcomes. Patients and Methods Patients diagnosed with oesophagogastric cancer between November 2019 and December 2023 were included in this retrospective study. Skeletal muscle index (SMI) and density (SMD) were assessed via CT scans at the L3 level. Myopenia and myosteatosis were defined according the Martin’s criteria: myopenia was defined in men by an SMI

Fields of Study & Subjects

Nutrition and Health in Aging Body Composition Measurement Techniques Inflammatory Biomarkers in Disease Prognosis

Publication details

Journal / source
Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B))
Publication date
1 January 2026
Language
EN